Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangjin Huang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Medical Genetics|August 26, 2020
Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domainFangjin Huang, Hisashi Tanaka, Beatrice S Knudsen, et al.
Diagnostic Pathology|September 20, 2017
Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrateZhaoxuan Ma, Stephen L Shiao, Emi J Yoshida, et al.
Scientific Reports|October 18, 2017
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcomeNathan Ing, Fangjin Huang, Andrew Conley, et al.
Frontiers in Immunology|January 9, 2019
Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue StainingJoshua Saylor, Zhaoxuan Ma, Helen S Goodridge, et al.
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Nature Medicine|November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axisMirja Rotinen, Sungyong You, Julie Yang, et al.
The Journal of Pathology. Clinical Research|October 28, 2016
Quantitative imaging for development of companion diagnostics to drugs targeting HGF/METFangjin Huang, Zhaoxuan Ma, Sara Pollan, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Medical Genetics|August 26, 2020
Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domainFangjin Huang, Hisashi Tanaka, Beatrice S Knudsen, et al.
Diagnostic Pathology|September 20, 2017
Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrateZhaoxuan Ma, Stephen L Shiao, Emi J Yoshida, et al.
Scientific Reports|October 18, 2017
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcomeNathan Ing, Fangjin Huang, Andrew Conley, et al.
Frontiers in Immunology|January 9, 2019
Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue StainingJoshua Saylor, Zhaoxuan Ma, Helen S Goodridge, et al.
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Nature Medicine|November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axisMirja Rotinen, Sungyong You, Julie Yang, et al.
The Journal of Pathology. Clinical Research|October 28, 2016
Quantitative imaging for development of companion diagnostics to drugs targeting HGF/METFangjin Huang, Zhaoxuan Ma, Sara Pollan, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Pageof 1